CBZ

CBIZ, Inc. (CBZ) - Q3 2024 10-Q Summary

Business Context and Reporting Period

This report covers the quarterly period ended September 30, 2024. CBIZ, Inc. is a diversified professional business services company operating through three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company serves small and medium-sized businesses, individuals, governmental entities, and not-for-profits primarily in the U.S. and Canada.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Q3 revenue increased 6.9% year-over-year, driven by a 5.1% increase in same-unit revenue and 1.9% contribution from acquisitions. YTD revenue grew 7.1%.
• Operating Expenses: Total operating expenses rose 7.0% in Q3. Excluding the impact of the deferred compensation plan, expenses increased 3.9%, driven by higher personnel costs ($7.8 million increase) and direct costs.
• Corporate G&A: Corporate general and administrative expenses surged 76.8% in Q3 to $23.2 million, primarily due to $6.9 million in legal and professional fees and $7.7 million in non-recurring transaction costs related to the Marcum acquisition.
• Other Income: Q3 included a $4.95 million gain on the sale of CBIZ KA Consulting Services. Other income also included a net gain of $8.4 million from the deferred compensation plan investments.
• Segment Performance: Financial Services revenue grew 8.0% (Q3) and 7.7% (YTD). Benefits and Insurance Services grew 3.7% (Q3) and 4.6% (YTD). National Practices grew 5.6% (Q3) and 11.7% (YTD).

Guidance, Outlook, and Risks

Subsequent Event - Marcum Transaction: On November 1, 2024, CBIZ completed the acquisition of Marcum LLP's non-attest business. The transaction involved $637.6 million in cash consideration and the issuance of approximately 14.3 million shares of common stock. To fund this, CBIZ entered into new $2.0 billion credit facilities, resulting in $1.465 billion in outstanding debt as of November 1, 2024.

Outlook: Management prioritizes maximizing cash flow to pay down debt to maintain liquidity for future strategic acquisitions. The company maintains a share repurchase program authorized for up to 5.0 million shares, expiring March 31, 2025.

Risks and Contingencies:

• Integration Risk: Significant risks exist regarding the successful integration of Marcum, including potential disruption to operations, loss of key personnel, and failure to achieve anticipated synergies.
• Legal Proceedings: CBIZ is a defendant in multidistrict litigation (MDL) regarding a May 2023 cyberattack on the MOVEit Transfer server. The outcome and potential losses are currently indeterminable. Additionally, a counterclaim against Zotec Partners resulted in a $3.1 million award to CBIZ, which is under appeal.
• Leverage: The Marcum transaction significantly increased the company's leverage, increasing sensitivity to interest rate fluctuations and potential covenant compliance challenges.

Investor Verification Checklist

• Debt Structure: Verify the terms and covenants of the new $2.0 billion credit facility entered into on November 1, 2024, and the resulting leverage ratio.
• Transaction Costs: Confirm the final purchase price allocation for the Marcum transaction and the impact of non-recurring transaction costs on future quarters.
• Deferred Compensation Impact: Review the volatility of the deferred compensation plan investments, which significantly impacted "Other income" and operating expenses in Q3.
• Legal Exposure: Monitor developments in the MOVEit cyberattack MDL for potential liability estimates.
• Integration Progress: Assess early indicators of Marcum integration success, specifically regarding client retention and personnel turnover.